SCHEMBL25170271

SCHEMBL25170271

N#CCc1cc(O)cc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA9 Q16790 1/20 0.48
MMP3 P08254 1/20 0.41
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HCAR1 Q9BXC0 1/20 0.36
ENPP2 Q13822 1/20 0.35
ACHE P22303 1/20 0.34
IDO1 P14902 2/20 0.34
ESR2 Q92731 3/20 0.33
ESR1 P03372 2/20 0.33
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
LTA4H P09960 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8657492 0.84 KDM4E (0.43) MMP3KDM4ETDP1ENPP2IDO1
SCHEMBL1019992 0.84 KDM4E (0.43) CA12CA1CA9MMP3KDM4E
SCHEMBL1050898 0.84 ACHE (0.48) MMP3KDM4ETDP1ENPP2ACHE
SCHEMBL1401399 0.79 CYP4F2 (0.41) MMP3KDM4ETDP1ENPP2ACHE
SCHEMBL14431663 0.77 KDM4E (0.38) MMP3KDM4ETDP1ENPP2IDO1
SCHEMBL585527 0.75 KDM4E (0.41) MMP3KDM4ETDP1HCAR1ENPP2
SCHEMBL7714628 0.75 ALDH1A1 (0.48) MMP3KDM4ETDP1HCAR1ENPP2
SCHEMBL20576683 0.75 KDM4E (0.37) MMP3KDM4ETDP1ENPP2ACHE
SCHEMBL332715 0.75 KDM4E (0.37) MMP3KDM4ETDP1ENPP2IDO1
SCHEMBL1072135 0.75 KDM4E (0.41) KDM4ETDP1ENPP2IDO1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281149-B2 Modulators of G-protein coupled receptors CARMOT THERAPEUTICS, INC. (US) 2025-04-22 US disclosed
US-20240383960-A1 Modulators of G-Protein Coupled Receptors CARMOT THERAPEUTICS INC. (US) 2024-11-21 US disclosed
CN-117980325-A Modulators of G-protein coupled receptors 卡莫特治疗学股份有限公司 2024-05-03 CN disclosed
EP-4337682-A2 MODULATORS OF G-PROTEIN COUPLED RECEPTORS Carmot Therapeutics Inc. (US) 2024-03-20 EP disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 US disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 US disclosed
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 US disclosed
WO-2022241287-A2 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. (US) 2022-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383960-A1 Modulators of G-Protein Coupled Receptors GIPR, GLP1R, GCGR CA12 3403/4885CA1 2955/4885CA9 2977/4885
US-12281149-B2 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR CA12 3422/4885CA1 2899/4885CA9 3101/4885
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR CA12 3422/4885CA1 2899/4885CA9 3101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.